|
cardiovascular diseases |
8 |
|
machine learning |
8 |
|
recurrent cardiovascular events |
8 |
|
risk prediction score |
8 |
|
stroke |
7 |
|
atrial fibrillation |
6 |
|
international normalized ratio |
5 |
|
non-vitamin k oral anticoagulants |
5 |
|
time in therapeutic range |
5 |
|
warfarin |
5 |
|
adult cardiology |
4 |
|
telemedicine |
4 |
|
apixaban |
3 |
|
border restriction |
3 |
|
coronavirus disease 2019 (covid-19) |
3 |
|
covid-19 |
3 |
|
device related thrombus |
3 |
|
epidemiology |
3 |
|
hyponatremia |
3 |
|
left atrial appendage occlusion |
3 |
|
microlife |
3 |
|
mobile app |
3 |
|
outcomes |
3 |
|
photoplethysmography |
3 |
|
screening |
3 |
|
sodium |
3 |
|
susceptible exposed infectious recovered (seir) model |
3 |
|
drug discovery |
2 |
|
gene therapy |
2 |
|
stem cell |
2 |
|
adult-onset still's disease (aosd) |
1 |
|
aortic valve stenosis |
1 |
|
autoimmune disease |
1 |
|
autoimmunity |
1 |
|
cancer |
1 |
|
cardiac intervention |
1 |
|
echocardiography |
1 |
|
heart valve prosthesis |
1 |
|
immune checkpoint inhibitor |
1 |
|
immunotherapy |
1 |
|
leukocyte |
1 |
|
mitral regurgitation |
1 |
|
mitral valve (mv) repair |
1 |
|
mrna vaccine |
1 |
|
myocarditis |
1 |
|
transcatheter aortic valve replacement |
1 |
|
transgenic mice |
1 |
|
vaccine |
1 |
|
valvular heart disease |
1 |
